IVPCARE Chosen in "The Dallas 100" for Sixth Consecutive Year

Frisco, Texas, November 18, 2003 - IVPCARE captured the number 53 spot on the Dallas 100 award list at the Thirteenth Annual Awards Dinner. This is IVPCARE's sixth consecutive year to be recognized as one of the 100 fastest growing privately held companies in the Dallas Metroplex. The award is presented by SMU's Cox School of Business Caruth Institute in conjunction with the CEO Institute and is a tribute to the vitality and entrepreneurial spirit of the emerging business community in the Dallas area.

IVPCARE President Von Best said, "We are honored to be recognized in The Dallas 100 and are thrilled that our company continues to grow strongly and steadily year after year. Our greatest inspiration is to improve the lives of our patients dealing with infertility, multiple sclerosis and arthritis. Our goal is to be successful as a company while minimizing the burden and stress felt by our customers is our greatest honor."

The companies chosen in The Dallas 100 have made significant contributions to the area by generating thousands of new jobs, increasing the tax base, and fostering North Texas' reputation as a premier economic development center. To qualify for The Dallas 100, a company must be a privately held corporation with a three-year sales history of increased percentage growth and dollar growth between 2000 and 2002. For more information on The Dallas 100 and a complete list of award winners, visit http://caruth.cox.smu.edu

About IVPCARE

IVPCARE is the largest privately held national specialty pharmacy offering clinical services and distribution of pharmaceuticals developed for chronic therapeutic indications.  IVPCARE provides comprehensive programs for patients, physicians, payors and pharmaceutical manufacturers for a growing number of disease states including hepatitis C, infertility, rheumatoid arthritis, multiple sclerosis, Crohn's disease and others.  Headquartered in Frisco, Texas, IVPCARE has distribution facilities there, as well as in Torrance, Calif., St. Louis, Mo., and Wilmington, Mass.